MA50141A - Procédés de purification de protéines de fusion d'albumine - Google Patents

Procédés de purification de protéines de fusion d'albumine

Info

Publication number
MA50141A
MA50141A MA050141A MA50141A MA50141A MA 50141 A MA50141 A MA 50141A MA 050141 A MA050141 A MA 050141A MA 50141 A MA50141 A MA 50141A MA 50141 A MA50141 A MA 50141A
Authority
MA
Morocco
Prior art keywords
fusion protein
protein purification
albumin fusion
purification processes
processes
Prior art date
Application number
MA050141A
Other languages
English (en)
Inventor
Are Bogsnes
Viveka Dolby
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MA50141A publication Critical patent/MA50141A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/16—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the fluid carrier
    • B01D15/166—Fluid composition conditioning, e.g. gradient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
MA050141A 2017-04-20 2018-04-19 Procédés de purification de protéines de fusion d'albumine MA50141A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17167261 2017-04-20

Publications (1)

Publication Number Publication Date
MA50141A true MA50141A (fr) 2020-07-29

Family

ID=58632195

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050141A MA50141A (fr) 2017-04-20 2018-04-19 Procédés de purification de protéines de fusion d'albumine

Country Status (6)

Country Link
US (2) US20200131225A1 (fr)
EP (1) EP3612558A1 (fr)
JP (1) JP2020517657A (fr)
CN (1) CN110770251A (fr)
MA (1) MA50141A (fr)
WO (1) WO2018193033A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10588980B2 (en) 2014-06-23 2020-03-17 Novartis Ag Fatty acids and their use in conjugation to biomolecules
CN113880908B (zh) * 2021-08-25 2024-05-14 北京伟德杰生物科技有限公司 纯化重组人血清白蛋白的融合蛋白的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
GB9526733D0 (en) * 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
GB9902000D0 (en) * 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
EP1274720A4 (fr) 2000-04-12 2004-08-18 Human Genome Sciences Inc Proteines fusionnees a l'albumine
KR101271635B1 (ko) * 2001-12-21 2013-06-12 휴먼 게놈 사이언시즈, 인코포레이티드 알부민 융합 단백질
EP1463752A4 (fr) 2001-12-21 2005-07-13 Human Genome Sciences Inc Proteines de fusion d'albumine
CN101172091B (zh) 2007-09-25 2011-04-27 北京美福源生物医药科技有限公司 含人血清白蛋白与皮肤细胞生长因子的融合蛋白护肤产品制备工艺和用途
EP1444986A1 (fr) * 2003-02-07 2004-08-11 Aventis Behring GmbH Preparation pharmaceutique pour l'amélioration du traitement des maladies liées à une coagulation sanguine diminuée
GB0305989D0 (en) * 2003-03-15 2003-04-23 Delta Biotechnology Ltd Agent
WO2005047337A1 (fr) * 2003-11-13 2005-05-26 Hanmi Pharmaceutical Co., Ltd. Composition pharmaceutique presentant une region de l'immunoglobuline fc comme excipient
JP2009504157A (ja) * 2005-08-12 2009-02-05 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド アルブミン融合タンパク質
EP2427486B1 (fr) * 2009-05-07 2015-02-25 Novozymes Biopharma DK A/S Procédé de purification de l'albumine
US20170204149A1 (en) * 2014-06-23 2017-07-20 Novartis Ag Hsa-gdf-15 fusion polypeptide and use thereof
CN106459222A (zh) 2014-06-24 2017-02-22 诺和诺德股份有限公司 Mic‑1融合蛋白及其用途
TN2016000578A1 (en) * 2014-07-30 2018-04-04 Ngm Biopharmaceuticals Inc Compositions and methods of use for treating metabolic disorders

Also Published As

Publication number Publication date
JP2020517657A (ja) 2020-06-18
US20220009958A1 (en) 2022-01-13
US20200131225A1 (en) 2020-04-30
CN110770251A (zh) 2020-02-07
EP3612558A1 (fr) 2020-02-26
WO2018193033A1 (fr) 2018-10-25

Similar Documents

Publication Publication Date Title
EP3493844A4 (fr) Protéine de liaison à l'albumine sérique à domaine unique
EP3880814A4 (fr) Protéine de fusion
IL281804A (en) Protein purification methods
MA50746A (fr) Protéines de fusion comprenant des enzymes d'enzymothérapie substitutive
EP3727636A4 (fr) Système de purification d'air
MA45684A (fr) Protéine d'apport du cerveau
EP3373970A4 (fr) Protéine de fusion nkg2d-ig pour l'immunothérapie contre le cancer
IL285146A (en) Methods of purifying fc-containing proteins
MA50908A (fr) Formulations de protéines de fusion vegfr-fc
IL261040B (en) Protein purification
EP3383418A4 (fr) Peptides slc45a2 pour l'immunothérapie
EP3589640A4 (fr) Purification de protéines avec la protéine l
EP3513821A4 (fr) Matériau de purification du sang
DK3464331T3 (da) Stabiliserede præfusions-rsv f-proteiner
GB201711481D0 (en) Protein purification
EP3438426A4 (fr) Système de purification d'échappement
ZA202102533B (en) Fusion protein
EP3801485A4 (fr) Procédés de purification de protéines et de peptides
EP3601572A4 (fr) Construction d'expression de protéine et procédés associés
EP3517149A4 (fr) Système d'épuration de sang
EP3431508A4 (fr) Protéine de fusion albumine sérique-hormone de croissance 20k
EP3794014A4 (fr) Agent d'activation de peptide
EP3649159C0 (fr) Protéine de fusion
IL265195A (en) Protein biomarkers for diseases associated with the contact activation system
EP3318575A4 (fr) Complexe d'albumine-chaîne de sucre